{
    "Trade/Device Name(s)": [
        "LIAISON\u00ae Helicobacter Antigen",
        "LIAISON\u00ae Helicobacter Antigen Control Set"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K181464",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053335",
        "K161139"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LYR",
        "JJX",
        "JJF"
    ],
    "Summary Letter Date": "June 5, 2018",
    "Summary Letter Received Date": "June 6, 2018",
    "Submission Date": "August 31, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3110",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents",
        "Single (Specified) analyte controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Helicobacter pylori antigen"
    ],
    "Specimen Type(s)": [
        "Stool"
    ],
    "Specimen Container(s)": [
        "LIAISON\u00ae Stool Extraction Device"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae XL Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Sandwich assay",
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control Set",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for LIAISON Helicobacter Antigen assay for qualitative detection of H. pylori antigen in stool using CLIA on the LIAISON XL Analyzer",
    "Indications for Use Summary": "Qualitative detection of H. pylori antigen in human stool to aid diagnosis of H. pylori infection and measure post-therapy response, performed on the LIAISON XL Analyzer, with controls to monitor assay performance",
    "fda_folder": "Microbiology"
}